BioHealth News Archive
Novavax reports positive phase 1 data on its Covid-19 vaccine candidate – Washington Business Journal
The study found the candidate elicits “robust antibody responses” and is well-tolerated, the company said Tuesday. Image: Novavax is advancing a Covid-19 vaccine candidate…
Read More
20/20 GeneSystems Wins Gold Medal in the 2020 Taipei Biotech Award for its OneTest Blood Test for Early Detection of Cancer | BioSpace
ROCKVILLE, Md.--(BUSINESS WIRE)-- 20/20 GeneSystems, Inc. is proud to announce that in partnership with Linkou Chang Gung Memorial Hospital, the largest hospital in Taiwan,…
Read More
The Frederick Innovative Technology Center’s (FITCI) Edge Accelerator Program Mentoring the Next Generation of Frederick, Maryland Life Science Startups · BioBuzz
The Frederick Innovative Technology Center business incubator and accelerator, or FITCI, as it is better known, has been a linchpin for the Frederick, Maryland…
Read More
Cystic Fibrosis Foundation and Longwood Fund Launch CF Incubator
Today the Cystic Fibrosis Foundation announced a collaboration with Longwood Fund, a biotech-focused venture capital firm, to accelerate innovative therapies for cystic fibrosis. Together,…
Read More
America’s Bio and Pharma Manufacturing Renaissance (Tuesday, September 15, 2020 1:00 – 4:00 pm EDT)
The Covid-19 Pandemic vividly demonstrates the need for rethinking ways to manufacture biological materials and create sustainable medical product supply lines for the United…
Read More
Emergent BioSolutions Announces Proposed Offering of $450 Million of Senior Unsecured Notes NYSE:EBS
GAITHERSBURG, Md., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) (the “Company”) announced today that it intends to offer $400 million aggregate…
Read More
Trump order threatens small biotechs driving COVID innovation | TheHill
Pfizer’s disclosure last week that it may reverse plans to in-shore manufacturing facilities and science jobs to the United States is just the tip…
Read More
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate | Novavax Inc. – IR Site
GAITHERSBURG, Md., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today…
Read More
TruGenomix co-founders hope to prevent severe PTSD – Sanford Health News
The two co-founders behind TruGenomix have a vision for helping veterans and others who might be prone to post-traumatic stress disorder (PTSD). A new…
Read More
Lurie Prize in Biomedical Sciences | FNIH
Each year, the FNIH recognizes outstanding achievements by a promising young scientist in biomedical research by bestowing the Lurie Prize in Biomedical Sciences, a…
Read More
Is Telemedicine Here to Stay?
Telemedicine is having its moment. Over the last few months, millions of people have relied on video or telephone calls to talk to their…
Read More
REGENXBIO Announces Additional Positive Interim Phase I/IIa Trial Update and Program Updates for RGX-314 for the Treatment of Wet AMD | BioSpace
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…
Read More
Save the Date! 2020 BioHealth Capital Region Forum
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
Jennifer Butler, Executive Vice President and General Manager, Innate Pharma US Inc. sits down with Rich Bendis for BioTalk
Jennifer Butler, Executive Vice President and General Manager, Innate Pharma US Inc. joins Rich Bendis on BioTalk to discuss her career, bringing Innate from…
Read MoreNIH Invests $248.7 Million to Ramp up COVID-19 Testing
Six months into the COVID-19 pandemic, the question of why tests that detect the presence of the SARS-CoV-2 virus are not faster, better, and…
Read More